THE US Food and Drug
Administration has issued a
warning over GlaxoSmithKline’s
seizure and bipolar drug Lamictal
(lamotrigine), which its says can
cause aseptic meningitis.
At present the FDA is working
with GSK to update the prescribing
and labelling information.
The agency said that patients on
Lamictal who present with
meningitis with no clear cause should
discontinue the drug immediately.
“Aseptic meningitis is a rare but
serious side effect of Lamictal use,”
said Russell Katz, director of the
Division of Neurology Products in
the FDA’s Center for Drug
Evaluation and Research.
“Patients that experience
symptoms should consult their
health care professional
immediately,” he added.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Aug 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.